These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34061123)

  • 1. Cushing Disease with Glucocorticoid-induced Positive Feedback-A New Subtype of Pituitary Corticotropinomas?
    Tóth M
    J Endocr Soc; 2021 Jun; 5(6):bvab079. PubMed ID: 34061123
    [No Abstract]   [Full Text] [Related]  

  • 2. PATHOGENESIS OF CUSHING DISEASE: AN UPDATE ON THE GENETICS OF CORTICOTROPINOMAS.
    Albani A; Perez-Rivas LG; Reincke M; Theodoropoulou M
    Endocr Pract; 2018 Oct; 24(10):907-914. PubMed ID: 30084690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACTH-Dependent Cyclic Cushing Syndrome Triggered by Glucocorticoid Excess Through a Positive-Feedback Mechanism.
    Seki Y; Morimoto S; Saito F; Takano N; Kimura S; Yamashita K; Yoshida N; Bokuda K; Sasaki N; Yatabe M; Watanabe D; Yatabe J; Ando T; Amano K; Kawamata T; Ichihara A
    J Clin Endocrinol Metab; 2019 May; 104(5):1788-1791. PubMed ID: 30561712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cellular and molecular basis for the selective desmopressin-induced ACTH release in Cushing disease patients: key role of AVPR1b receptor and potential therapeutic implications.
    Luque RM; Ibáñez-Costa A; López-Sánchez LM; Jiménez-Reina L; Venegas-Moreno E; Gálvez MA; Villa-Osaba A; Madrazo-Atutxa AM; Japón MA; de la Riva A; Cano DA; Benito-López P; Soto-Moreno A; Gahete MD; Leal-Cerro A; Castaño JP
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4160-9. PubMed ID: 23884782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus.
    Huizenga NA; de Lange P; Koper JW; Clayton RN; Farrell WE; van der Lely AJ; Brinkmann AO; de Jong FH; Lamberts SW
    J Clin Endocrinol Metab; 1998 Mar; 83(3):917-21. PubMed ID: 9506748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors.
    Korbonits M; Bujalska I; Shimojo M; Nobes J; Jordan S; Grossman AB; Stewart PM
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2728-33. PubMed ID: 11397878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms of Glucocorticoid Resistance in Corticotropinomas: New Developments and Drug Targets.
    Ciato D; Albani A
    Front Endocrinol (Lausanne); 2020; 11():21. PubMed ID: 32117053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Silent"corticotropinoma.
    Pawlikowski M; Kunert-Radek J; Radek M
    Neuro Endocrinol Lett; 2008 Jun; 29(3):347-50. PubMed ID: 18580839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid receptor gene polymorphisms in ACTH-secreting pituitary tumours.
    Antonini SR; Latronico AC; Elias LL; Cukiert A; Machado HR; Liberman B; Mendonca BB; Moreira AC; Castro M
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):657-62. PubMed ID: 12390341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large Genomic Aberrations in Corticotropinomas Are Associated With Greater Aggressiveness.
    Tatsi C; Pankratz N; Lane J; Faucz FR; Hernández-Ramírez LC; Keil M; Trivellin G; Chittiboina P; Mills JL; Stratakis CA; Lodish MB
    J Clin Endocrinol Metab; 2019 May; 104(5):1792-1801. PubMed ID: 30597087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic insights into Cushing syndrome.
    Assié G
    Ann Endocrinol (Paris); 2018 Jun; 79(3):119-122. PubMed ID: 29735160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
    Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
    Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Corticotropinomas. Early diagnosis and treatment (lecture)].
    Semin VE; Trunin IuK
    Probl Endokrinol (Mosk); 1994; 40(1):31-5. PubMed ID: 8165211
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein.
    Dayanithi G; Antoni FA
    Endocrinology; 1989 Jul; 125(1):308-13. PubMed ID: 2544406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cables1 Gene in Glucocorticoid Regulation of Pituitary Corticotrope Growth and Cushing Disease.
    Roussel-Gervais A; Couture C; Langlais D; Takayasu S; Balsalobre A; Rueda BR; Zukerberg LR; Figarella-Branger D; Brue T; Drouin J
    J Clin Endocrinol Metab; 2016 Feb; 101(2):513-22. PubMed ID: 26695862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene.
    Karl M; Von Wichert G; Kempter E; Katz DA; Reincke M; Mönig H; Ali IU; Stratakis CA; Oldfield EH; Chrousos GP; Schulte HM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):124-9. PubMed ID: 8550738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations.
    Daniel E; Newell-Price J
    F1000Res; 2017; 6():613. PubMed ID: 28529722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific and time-dependent effects of glucocorticoid receptor agonist RU28362 on stress-induced pro-opiomelanocortin hnRNA, c-fos mRNA and zif268 mRNA in the pituitary.
    Ginsberg AB; Frank MG; Francis AB; Rubin BA; O'Connor KA; Spencer RL
    J Neuroendocrinol; 2006 Feb; 18(2):129-38. PubMed ID: 16420282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for GPR101 defects in pediatric pituitary corticotropinomas.
    Trivellin G; Correa RR; Batsis M; Faucz FR; Chittiboina P; Bjelobaba I; Larco DO; Quezado M; Daly AF; Stojilkovic SS; Wu TJ; Beckers A; Lodish M; Stratakis CA
    Endocr Relat Cancer; 2016 Jun; 23(5):357-365. PubMed ID: 26962002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.